Double-Blind, Placebo Controlled, Randomized Study of Vardenafil to Determine Efficacy on Erectile Dysfunction (ED) in Men With ED and Metabolic Syndrome (ED-METABOLIC).

Trial Profile

Double-Blind, Placebo Controlled, Randomized Study of Vardenafil to Determine Efficacy on Erectile Dysfunction (ED) in Men With ED and Metabolic Syndrome (ED-METABOLIC).

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Jan 2014

At a glance

  • Drugs Vardenafil (Primary)
  • Indications Erectile dysfunction
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms ED-METABOLIC
  • Sponsors Bayer
  • Most Recent Events

    • 21 Nov 2012 New source identifid and integrated (German Clinical Trials Register: DRKS00004131).
    • 21 Apr 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2008-002140-41).
    • 20 Jan 2010 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top